Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing

This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Wound Healing Mohs Micrographic Surgery Oculofacial Reconstruction

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Kentucky

Lexington, Kentucky, 40508, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients >18 years of age
follow-up at specified intervals (1 week/6 week/3 months) in an office setting
can give informed consent
no patients will be excluded on the basis of gender, ethnicity, or religious background

Exclusion criteria

Patients <18 years of age or >100
allergy to pectin, gelatin, and sodium carboxymethylcellulose
adults with impaired consent capacity
incarcerated individuals.

Treatment and study plan

Hydrocolloid Wound Dressing

Device

one time hydrocolloid dressing application

Other names: DuoDERM Extra Thin dressing

Primary outcomes

Number of participants with wound dehiscence

Time frame: 3 months

YES/NO type question if wound dehiscence is present after removal of the patch

Secondary outcomes

Patient and Observer Scar Assessment Scale

Time frame: 3 months

Patient and Observer Scar Assessment Scale filled out by both patient and provider at postoperative visit of both HCD Dressing and ointment. This survey is scaled from 0-10, with 0 being normal skin and 10 being very different skin. Lower scores are desired on this survey.

Sponsors and collaborators

Lead sponsor

Janice Hernandez, MD

Other

Registry information

Acronym: HCD Wound Heal

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Jul 20, 2025
Registry last updated: Sep 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting